Skip to main content
Lawrence Steinman, MD, Neurology, Palo Alto, CA

LawrenceSteinmanMD

Neurology • Palo Alto, CA

Hospital/Neurohospitalist

Professor, Neurology & Neurological Sciences, Stanford University Medical Center

Join to view full profile

Dr. Steinman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Steinman's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-498-5710

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
  • Weizmann Institute
    Weizmann InstitutePost-Doctoral Fellowship, 1975 - 1977
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1974 - 1975
  • Stanford Health Care
    Stanford Health CareInternship, Transitional Year, 1973 - 1974
  • Harvard Medical School
    Harvard Medical SchoolClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Elected Member National Academy of Sciences, 2015
  • Fellow American Association Advancement of Science AAAS, 2015
  • Charcot Prize for Lifetime Achievement in MS Researcj International Federation of MS Societies, 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Engineered DNA Plasmid Reduces Immunity to Dystrophin While Improving Muscle Force in a Model of Gene Therapy of Duchenne Dystrophy  
    Lawrence Steinman, William H Robinson, Proceedings of the National Academy of Sciences

Press Mentions

  • Experts Urge Genetic Screening for MS Patients to Help Prevent Rare Treatment-Related Fatal Infection
    Experts Urge Genetic Screening for MS Patients to Help Prevent Rare Treatment-Related Fatal InfectionMarch 17th, 2023
  • Leading MS/PML Experts Recommend Genetic Testing to Prevent Fatal Brain Infection
    Leading MS/PML Experts Recommend Genetic Testing to Prevent Fatal Brain InfectionMarch 16th, 2023
  • TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (Ublituximab-Xiiy) in Multiple Sclerosis to Be Presented at the American Academy of Neurology 75th Annual Meeting
    TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (Ublituximab-Xiiy) in Multiple Sclerosis to Be Presented at the American Academy of Neurology 75th Annual MeetingMarch 3rd, 2023
  • Join now to see all

Professional Memberships

Dr. Lawrence Steinman, Dr. Lawrence Steinman, MD, Dr. L Steinman